혈당 측정기 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 당뇨병 유형별, 접속 기능별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Glucometer Market size was valued at USD 31.25 Billion in 2024 and is poised to grow from USD 35.31 Billion in 2025 to USD 93.86 Billion by 2033, growing at a CAGR of 13.0% during the forecast period (2026-2033).

The global glucometer market consists of blood-glucose meters, test strips, and digital platforms that assist individuals in managing diabetes through timely glycemic monitoring. The increasing prevalence of diabetes, affecting millions worldwide, underscores the essential need for effective glucose control to avert serious complications. The market has evolved significantly since the introduction of handheld devices, propelled by innovative reimbursement strategies and the integration of digital technologies that offer users actionable insights from glucose data. With advancements in AI, glucometers now provide enhanced accuracy and intuitive management experiences. These technologies enable real-time alerts and trend predictions, fostering a proactive approach to diabetes care. Consequently, manufacturers are forging partnerships and adapting their products to expand market reach and enhance user engagement, ultimately reinforcing growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glucometer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glucometer Market Segments Analysis

Global glucometer market is segmented by product type, diabetes type, connectivity, end user and region. Based on product type, the market is segmented into Self-Monitoring Blood Glucose (SMBG) Meters, Continuous Glucose Monitoring (CGM) Systems and Flash Glucose Monitoring Systems. Based on diabetes type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes. Based on connectivity, the market is segmented into Bluetooth-Enabled, NFC (Near Field Communication) and Wired (USB). Based on end user, the market is segmented into Homecare / Self-Monitoring, Hospitals & Clinics and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glucometer Market

The increasing prevalence of diabetes worldwide significantly boosts the demand for self-monitoring solutions, leading both individuals and healthcare professionals to embrace glucometers as vital instruments for regular blood glucose monitoring. This growing awareness surrounding effective disease management promotes consistent testing, ultimately enhancing the sales of glucometers and their associated consumables. In response, manufacturers are broadening their distribution channels and launching user-friendly designs, which further propels market growth as more patients look for dependable, at-home monitoring alternatives to aid in therapeutic decision-making and enhance their overall health outcomes in daily routines.

Restraints in the Global Glucometer Market

The Global Glucometer market faces significant challenges primarily due to the high costs associated with advanced glucometers and their corresponding disposable test strips. This premium pricing presents financial barriers, particularly for patients in low-income areas and those without insurance coverage. High out-of-pocket expenses discourage regular self-testing, resulting in diminished demand for both the devices and their consumables. Additionally, healthcare systems burdened by budget limitations may restrict reimbursements for newer models, further hindering their market adoption. Thus, cost sensitivity among potential users ultimately restricts market growth, as many prioritize financial considerations over the perceived clinical advantages of these advanced testing solutions.

Market Trends of the Global Glucometer Market

The Global Glucometer market is witnessing a robust trend driven by the integration of digital technologies that enhance patient engagement and adherence to diabetes management. The convergence of glucometer devices with mobile platforms and cloud-based health applications has led to advancements such as Bluetooth connectivity and open APIs, facilitating real-time data transfer to electronic health records and telemedicine. This technological synergy empowers healthcare providers to optimize therapy adjustments rapidly while offering patients features like automated reminders and personalized trend visualizations. Consequently, the adoption of connected glucometers is becoming pivotal in value-based care models, demonstrating their role in improving long-term health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Glucometer Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Self-Monitoring Blood Glucose (SMBG) Meters
• Continuous Glucose Monitoring (CGM) Systems
  • Sensors
  • Transmitters & Receivers
  • Insulin Pump Integration
• Flash Glucose Monitoring Systems

Global Glucometer Market Size by Diabetes Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Global Glucometer Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Bluetooth-Enabled
• NFC (Near Field Communication)
• Wired (USB)

Global Glucometer Market Size by End User & CAGR (2026-2033)

• Market Overview
• Homecare / Self-Monitoring
• Hospitals & Clinics
• Diagnostic Laboratories

Global Glucometer Market Size & CAGR (2026-2033)

• North America (Product Type, Diabetes Type, Connectivity, End User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, Connectivity, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, Connectivity, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, Connectivity, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, Connectivity, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (FreeStyle)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Accu-Chek)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Medical Inc. (B. Braun)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan Inc. (Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSig Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agiliti Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovaBay Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlucoTrack Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovioSense BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qualcomm Life Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trilogy Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glucose Buddy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations